Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Other Non Operating Income (2018 - 2020)

Creative Medical Technology Holdings (CELZ) has disclosed Other Non Operating Income for 4 consecutive years, with $28.5 million as the latest value for Q1 2021.

  • On a quarterly basis, Other Non Operating Income changed N/A to $28.5 million in Q1 2021 year-over-year; TTM through Mar 2021 was -$5.5 million, a 16.27% decrease, with the full-year FY2020 number at -$34.0 million, down 567.35% from a year prior.
  • Other Non Operating Income was $28.5 million for Q1 2021 at Creative Medical Technology Holdings, up from -$34.0 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $28.5 million in Q1 2021 to a low of -$34.0 million in Q4 2020.
  • A 4-year average of -$1.3 million and a median of -$121264.0 in 2018 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 131.58% in 2019; the steepest drop was 5277.75% in 2019.
  • Creative Medical Technology Holdings' Other Non Operating Income stood at -$88244.0 in 2018, then tumbled by 5277.75% to -$4.7 million in 2019, then tumbled by 616.06% to -$34.0 million in 2020, then surged by 183.8% to $28.5 million in 2021.
  • Per Business Quant, the three most recent readings for CELZ's Other Non Operating Income are $28.5 million (Q1 2021), -$34.0 million (Q4 2020), and -$4.7 million (Q4 2019).